Experiment 69618
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | CIEZA,A: MAIER,P: POPPEL,E:. (2003). EFFECTS OF GINKGO BILOBA ON MENTAL FUNCTIONING IN HEALTHY VOLUNTEERS.. 34(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | FOUND FOR BOTH MOTOR AND EMOTIONAL EVALUATION. THIS STUDY DID NOT REVEAL UNKNOWN DRUG-INDUCED SIDE EFFECTS OR INTOLERANCE. NO SERIOUS ADVERSE EVENTS WERE OBSERVED DURING THE STUDY. MENTAL HEALTH AS WELL AS SELF-ESTIMATED QUALITY OF LIFE WERE SIGNIFICANT IN FAVOR OF EGB 761. NO INTERGROUP DIFFERENCES WERE FOUND IN SELF ESTIMATED GENERAL HEALTH. SECONDARY OUTCOMES SUPPORTING THE NOTION OF SUPERIORITY OF THE ACTIVE DRUG WERE STUDY WAS CONDUCTED. 66 HEALTHY VOLUNTEERS AGED BETWEEN 50 AND 65 YRS WITHOUT AGE-ASSOCIATED COGNITIVE IMPAIRMENT WERE RANDOMIZED, 32 INTO THE PLACEBO AND 34 INTO EGB 761-TREATMENT GROUP (240 MG, T.I.D.), INTERGROUP DIFFERENCES IN SELF-ESTIMATED THE OBJECTIVE OF THE PRESENT STUDY WAS TO EVALUATE THE RELATIVELY SHORT-TERM (I.E. 4 WKS) EFFECTS OF EGB 761 ON MENTAL FUNCTIONING AND QUALITY OF LIFE IN HEALTHY VOLUNTEERS. A 4-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP A COMMERCIAL PRODUCT, EGB-761, WAS USED. |
| Dose amount | 720.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ACETONE EXT |
| Gender | GIVEN TO BOTH SEXES |